SPECIFICS OF THE EARLY PHASES OF CLINICAL TRIALS: FROM SCIENCE TO PERSON

The article focuses on the form of ethical controversy of the new drugs studies on humans. The issue is at its most importance in early phases of clinical trials that resemble an experiment, therefore requiring specific regulation. Has the difficulties been resolved, that are related to ethical aspe...

Full description

Saved in:
Bibliographic Details
Main Authors: I. G. Gordeev, E. O. Taratukhin
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2015-09-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/299
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849691048592277504
author I. G. Gordeev
E. O. Taratukhin
author_facet I. G. Gordeev
E. O. Taratukhin
author_sort I. G. Gordeev
collection DOAJ
description The article focuses on the form of ethical controversy of the new drugs studies on humans. The issue is at its most importance in early phases of clinical trials that resemble an experiment, therefore requiring specific regulation. Has the difficulties been resolved, that are related to ethical aspects of human participants in new drugs investigation? Are not there any aspects that require thorough interdisciplinary workout, but being covered by strict regulation? Authors try to answer these questions taking into account a biosocial nature of the object of investigations.
format Article
id doaj-art-6c8c4ac5124b4e46bec46bb86dbef899
institution DOAJ
issn 1560-4071
2618-7620
language Russian
publishDate 2015-09-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj-art-6c8c4ac5124b4e46bec46bb86dbef8992025-08-20T03:21:09Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202015-09-0109767910.15829/1560-4071-2015-9-76-79299SPECIFICS OF THE EARLY PHASES OF CLINICAL TRIALS: FROM SCIENCE TO PERSONI. G. Gordeev0E. O. Taratukhin1Russian National Research Medical University named after N.I. Pirogov, MoscowRussian National Research Medical University named after N.I. Pirogov, MoscowThe article focuses on the form of ethical controversy of the new drugs studies on humans. The issue is at its most importance in early phases of clinical trials that resemble an experiment, therefore requiring specific regulation. Has the difficulties been resolved, that are related to ethical aspects of human participants in new drugs investigation? Are not there any aspects that require thorough interdisciplinary workout, but being covered by strict regulation? Authors try to answer these questions taking into account a biosocial nature of the object of investigations.https://russjcardiol.elpub.ru/jour/article/view/299evidence based medicineethicsinformed consentfirst phasesecond phase
spellingShingle I. G. Gordeev
E. O. Taratukhin
SPECIFICS OF THE EARLY PHASES OF CLINICAL TRIALS: FROM SCIENCE TO PERSON
Российский кардиологический журнал
evidence based medicine
ethics
informed consent
first phase
second phase
title SPECIFICS OF THE EARLY PHASES OF CLINICAL TRIALS: FROM SCIENCE TO PERSON
title_full SPECIFICS OF THE EARLY PHASES OF CLINICAL TRIALS: FROM SCIENCE TO PERSON
title_fullStr SPECIFICS OF THE EARLY PHASES OF CLINICAL TRIALS: FROM SCIENCE TO PERSON
title_full_unstemmed SPECIFICS OF THE EARLY PHASES OF CLINICAL TRIALS: FROM SCIENCE TO PERSON
title_short SPECIFICS OF THE EARLY PHASES OF CLINICAL TRIALS: FROM SCIENCE TO PERSON
title_sort specifics of the early phases of clinical trials from science to person
topic evidence based medicine
ethics
informed consent
first phase
second phase
url https://russjcardiol.elpub.ru/jour/article/view/299
work_keys_str_mv AT iggordeev specificsoftheearlyphasesofclinicaltrialsfromsciencetoperson
AT eotaratukhin specificsoftheearlyphasesofclinicaltrialsfromsciencetoperson